Relevant bibliographies by topics / Cerebral FDG PET

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Book chapters
  4. Conference papers

Academic literature on the topic 'Cerebral FDG PET'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cerebral FDG PET.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cerebral FDG PET"

1

Høilund-Carlsen, Poul F., Mona-Elisabeth Revheim, Tommaso Costa, et al. "FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls." Diagnostics 13, no. 13 (2023): 2254. http://dx.doi.org/10.3390/diagnostics13132254.

Full text
Abstract:
In June 2021, the US Federal Drug and Food Administration (FDA) granted accelerated approval for the antibody aducanumab and, in January 2023, also for the antibody lecanemab, based on a perceived drug-induced removal of cerebral amyloid-beta as assessed by amyloid-PET and, in the case of lecanemab, also a presumption of limited clinical efficacy. Approval of the antibody donanemab is awaiting further data. However, published trial data indicate few, small and uncertain clinical benefits, below what is considered “clinically meaningful” and similar to the effect of conventional medication. Fur
APA, Harvard, Vancouver, ISO, and other styles
2

Reale, Giuseppe, Augusto Fusco, Fabrizio Cocciolillo, et al. "Live Effects of Anodal and Cathodal Transcranial Direct Current Stimulation on Brain Metabolism in a Patient with Typical Hemorrhagic Stroke: A Case Study." Brain Sciences 15, no. 6 (2025): 594. https://doi.org/10.3390/brainsci15060594.

Full text
Abstract:
In this study, we aimed to assess the effects of transcranial direct current stimulation (tDCS) stimulation on brain metabolism in a patient with typical hemorrhagic stroke in a subacute phase. The patient was evaluated with 18F-FDG PET (18F-fluoro-2-deoxy-D-glucose positron emission tomography) during tDCS brain stimulation at 6, 8, and 10 weeks from the event. The patient underwent the following protocol: baseline cerebral 18F-FDG-PET (T0); cerebral 18F-FDG-PET during anodal-tDCS on the affected hemisphere (T1); and cerebral 18F-FDG-PET during cathodal-tDCS on the unaffected hemisphere (T2).
APA, Harvard, Vancouver, ISO, and other styles
3

Renard, Dimitri, Sebastien Dufour, Laurent Collombier, and Pierre Labauge. "Cerebral FDG-PET Hypermetabolism in Carcinomatous Meningitis." European Neurology 66, no. 6 (2011): 332–33. http://dx.doi.org/10.1159/000334096.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Moloney, Patrick, Ruth Boylan, Marwa Elamin, Sean O’Riordan, Ronan Killeen, and Christopher McGuigan. "Semi-quantitative analysis of cerebral FDG-PET reveals striatal hypermetabolism and normal cortical metabolism in a case of VGKCC limbic encephalitis." Neuroradiology Journal 30, no. 2 (2017): 160–63. http://dx.doi.org/10.1177/1971400916689578.

Full text
Abstract:
In the context of delayed autoimmune encephalitis antibody results, functional imaging can support the diagnosis of limbic encephalitis associated with anti-voltage-gated potassium channel complex (VGKCC) antibodies. Here we present a typical case of VGKCC encephalitis in a 69-year-old woman whose symptoms responded to plasmapheresis. A cerebral 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) scan performed prior to commencing treatment revealed striatal hypermetabolism assessed qualitatively and semi-quantitatively, with normal uptake in the cortex and cerebellum when anal
APA, Harvard, Vancouver, ISO, and other styles
5

Ayituhongman, Ameina, Zhang Qizhou, Qin Yongde, Amina Yibulayin, Li Yubin, and Li Xiaohong. "Application of 11C-CHO in the imaging of cerebral alveolar echinococcosis: A prospective study." Medicine 104, no. 21 (2025): e42191. https://doi.org/10.1097/md.0000000000042191.

Full text
Abstract:
11C-acetylcholine (11C-CHO) is a positron emission tomography (PET) radiotracer that has been utilized in the diagnosis and treatment of prostate, esophageal, and lung cancers. This preliminary study aimed to assess the feasibility of using 11C-CHO PET/computed tomography (CT) for imaging cerebral alveolar echinococcosis (CAE). In a prospective single-center study, patients with CAE underwent 18F-fludeoxyglucose (18F-FDG) and 11C-CHO PET/CT imaging. The number and location of lesions detected by the 2 tracers were compared, along with determining the maximum standard uptake value (SUVmax) of t
APA, Harvard, Vancouver, ISO, and other styles
6

Durand-Martel, Pascali, Dominic Tremblay, Catherine Brodeur, and Nancy Paquet. "Autopsy as Gold Standard in FDG-PET Studies in Dementia." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 37, no. 3 (2010): 336–42. http://dx.doi.org/10.1017/s0317167100010222.

Full text
Abstract:
Positron emission tomography (PET) imaging with F18-fluorodeoxyglucose (FDG) is increasingly used as an adjunct to clinical evaluation in the diagnosis of dementia. Considering that most FDG-PET studies in dementia use clinical diagnosis as gold standard and that clinical diagnosis is approximately 80% sensitive or accurate, we aim to review the evidence-based data on the diagnostic accuracy of brain FDG-PET in dementia when cerebral autopsy is used as gold standard. We searched the PubMed and Medline databases for dementia-related articles that correlate histopathological diagnosis at autopsy
APA, Harvard, Vancouver, ISO, and other styles
7

Høilund-Carlsen, Poul F., Abass Alavi, and Jorge R. Barrio. "PET/CT/MRI in Clinical Trials of Alzheimer’s Disease." Journal of Alzheimer's Disease 101, s1 (2024): S579—S601. http://dx.doi.org/10.3233/jad-240206.

Full text
Abstract:
With the advent of PET imaging in 1976, 2-deoxy-2-[18F]fluoro-D-glucose (FDG)-PET became the preferred method for in vivo investigation of cerebral processes, including regional hypometabolism in Alzheimer’s disease. With the emergence of amyloid-PET tracers, [11C]Pittsburgh Compound-B in 2004 and later [18F]florbetapir, [18F]florbetaben, and [18F]flumetamol, amyloid-PET has replaced FDG-PET in Alzheimer’s disease anti-amyloid clinical trial treatments to ensure “amyloid positivity” as an entry criterion, and to measure treatment-related decline in cerebral amyloid deposits. MRI has been used
APA, Harvard, Vancouver, ISO, and other styles
8

Heckmann, Josef G., Wolfgang Niedermeier, Markus Büchner, and Bernhard Scher. "Distinctive FDG-PET/CT Findings in Acute Neurological Hospital Care." Neurohospitalist 9, no. 2 (2018): 93–99. http://dx.doi.org/10.1177/1941874418805339.

Full text
Abstract:
A compilation of 6 distinctive 18F-fluorodeoxyglucose positron emission tomography (PET) combined with computed tomography (CT) findings in the acute setting of neurohospital care is presented. In case 1, PET/CT allowed the final diagnosis of circumscribed ischemic infarction by demonstrating a clear pattern of luxury perfusion. In case 2, diagnosis of thalamic abscess was made, whereby PET/CT demonstrated an empty zone. Hypermetabolic enlarged hilar lymph nodes and hypermetabolic spinal lumbar roots in PET/CT led to the diagnosis of neurosarcoidosis in case 3. In case 4, a hypermetabolic brai
APA, Harvard, Vancouver, ISO, and other styles
9

Seiffert, Alexander P., Adolfo Gómez-Grande, Alberto Villarejo-Galende, et al. "High Correlation of Static First-Minute-Frame (FMF) PET Imaging after 18F-Labeled Amyloid Tracer Injection with [18F]FDG PET Imaging." Sensors 21, no. 15 (2021): 5182. http://dx.doi.org/10.3390/s21155182.

Full text
Abstract:
Dynamic early-phase PET images acquired with radiotracers binding to fibrillar amyloid-beta (Aβ) have shown to correlate with [18F]fluorodeoxyglucose (FDG) PET images and provide perfusion-like information. Perfusion information of static PET scans acquired during the first minute after radiotracer injection (FMF, first-minute-frame) is compared to [18F]FDG PET images. FMFs of 60 patients acquired with [18F]florbetapir (FBP), [18F]flutemetamol (FMM), and [18F]florbetaben (FBB) are compared to [18F]FDG PET images. Regional standardized uptake value ratios (SUVR) are directly compared and intrap
APA, Harvard, Vancouver, ISO, and other styles
10

Maza, Sofiane, Ralph Buchert, Winfried Brenner, et al. "Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma." Radiology and Oncology 47, no. 2 (2013): 103–10. http://dx.doi.org/10.2478/raon-2013-0016.

Full text
Abstract:
Background. Positron emission tomography (PET) with F-18-labeled fluorodeoxyglucose (FDG) provides remarkable accuracy in detection, treatment monitoring and follow-up of systemic malignant lymphoma. Its value in the management of patients with primary central nervous system lymphoma (PCNSL) is less clear. Patients and methods. In a prospective trial, 42 FDG-PET examinations were performed in ten immunocompetent patients with newly diagnosed or recurrent PCNSL before and repeatedly during and after the treatment. Brain and whole body FDG-PET were compared to brain MRI and extra-cerebral CT, re
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Cerebral FDG PET"

1

London, Kevin Ian. "Cerebral F18 -FDG PET CT in Children: Patterns during Normal Childhood and Clinical Application of Statistical Parametric Mapping." Thesis, The University of Sydney, 2015. http://hdl.handle.net/2123/13962.

Full text
Abstract:
The first aim was to recruit and analyse a high quality dataset of cerebral FDG PET CT scans in neurologically normal children. Using qualitative, semi-quantitative and statistical parametric mapping (SPM) techniques, the results showed that a pattern of FDG uptake similar to adults does not occur by one year of age as was previously believed, but the regional FDG uptake changes throughout childhood driven by differing age related regional rates of increasing FDG uptake. The second aim was to use this normal dataset in the clinical analysis of cerebral FDG PET CT scans in children with epileps
APA, Harvard, Vancouver, ISO, and other styles
2

Pifarré, Montaner Paloma. "técnica de relajación vs fármaco de síntesis en el tratamiento de la ansiedad del paciente oncológico: estudio del metabolismo cerebral mediante Pet con 18f-fluorodesoxiglucosa (fdg)." Doctoral thesis, Universitat Autònoma de Barcelona, 2014. http://hdl.handle.net/10803/283925.

Full text
Abstract:
Existe un crecimiento progresivo de la utilización de terapias naturales (TN) en occidente y especialmente en los pacientes oncológicos. El cáncer es una de los problemas de salud fundalmentales de nuestra sociedad. Cuando existe una sospecha o diagnóstico de cáncer, los estudios de diagnóstico por la imagen tienen un papel fundalmental en la actividad clínica de este grupo de pacientes. Estos estudios pueden conllevar un grado importante de ansiedad. La tesis tiene dos objetivos fundamentales. El primero es evaluar el grado de ansiedad que presentan los pacientes oncológicos que se realizan u
APA, Harvard, Vancouver, ISO, and other styles
3

Font, Planells Mireia. "Alucinaciones auditivas en la esquizofrenia: estudio del metabolismo cerebral mediante PET con F18-FDG durante el primer episodio psicótico, tras remisión clínica y tras estimulación auditivo-lingüística." Doctoral thesis, Universitat de Barcelona, 2006. http://hdl.handle.net/10803/2693.

Full text
Abstract:
HIPÓTESIS DE TRABAJO: <br/><br/>Las alucinaciones auditivas verbales (AAV) endógenas de los pacientes con esquizofrenia se asocian a la activación de áreas cerebrales especializadas en la percepción del lenguaje externo tales como el córtex auditivo primario y secundario, las áreas de Broca y Wernicke, el complejo amígdalo-hipocampal, y el córtex singular anterior.<br/><br/>OBJETIVO GENERAL: <br/><br/>Evaluar el metabolismo cerebral regional mediante PET F18-FDG en un grupo homogéneo de pacientes con esquizofrenia en su primer episodio psicótico y con AAV prominentes, basalmente durante la enf
APA, Harvard, Vancouver, ISO, and other styles
4

Rozenblum, Laura. "Nouveaux biomarqueurs d'imagerie pour la prise en charge des lymphomes primitifs du système nerveux central : études en TEP-IRM au 18F-FDG et à la 18F-FLUDARABINE." Electronic Thesis or Diss., Sorbonne université, 2024. https://accesdistant.sorbonne-universite.fr/login?url=https://theses-intra.sorbonne-universite.fr/2024SORUS150.pdf.

Full text
Abstract:
Le lymphome primitif du système nerveux central (LPSNC) est une pathologie au pronostic sombre, dont l'incidence est en hausse, notamment chez les patients âgés et immunocompétents. La démarche thérapeutique pour les patients atteints de LPSNC s'appuie sur l'évaluation de deux indicateurs pronostiques établis : l'âge et le performans status. Néanmoins, la nécessité d'améliorer les stratégies thérapeutiques actuelles, centrées sur une poly-chimiothérapie d'induction à base de méthotrexate à haute dose suivie potentiellement par un traitement d'entretien, a suscité un intérêt croissant dans l'id
APA, Harvard, Vancouver, ISO, and other styles
5

Boschi, Filippo. "Imaging quantitativo cerebrale in pazienti affetti da patologie neurodegenerative con traccianti PiB e FDG marcati con 18-F." Master's thesis, Alma Mater Studiorum - Università di Bologna, 2017. http://amslaurea.unibo.it/13506/.

Full text
Abstract:
Il numero di casi riguardanti patologie neurodegenerative che colpiscono il sistema nervoso centrale sotto forma di demenza aumenta di anno in anno. Si ha quindi la necessità di individuare la presenza della malattia non solo a livello qualitativo, ovvero tramite la sola diagnosi del medico, ma anche a livello quantitativo, cercando di elaborare un metodo di analisi che tenga conto della variabilità tra individuo e individuo, ma che rimanga applicabile per la maggior parte della popolazione. In questo lavoro di tesi sono stati utilizzati due metodi di analisi statistica di immagini PET cerebra
APA, Harvard, Vancouver, ISO, and other styles
6

Maggiore, L. "Analisi del metabolismo cerebrale mediante FDG-PET nella malattia di Alzheimer e nei sottotipi di mild cognitive impairment med 26 : dottorato di ricerca in scienze neurologiche e del dolore : tesi di dottorato." Doctoral thesis, Università degli Studi di Milano, 2008. http://hdl.handle.net/2434/61193.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Santos, Rute Isabel Costa. "easyPET-3D & 18F-FDG no estudo funcional cerebral em roedores: exposição crónica a cocaína e potencial terapêutico da quercetina." Master's thesis, 2020. http://hdl.handle.net/10316/93924.

Full text
Abstract:
Trabalho de Projeto do Mestrado Integrado em Engenharia Biomédica apresentado à Faculdade de Ciências e Tecnologia<br>A toxicodependência é um problema mundial que acarreta consequências graves para os indivíduos envolvidos, direta e indiretamente, bem como para a sociedade. A cocaína é a segunda droga mais consumida em todo o mundo, tendo sido estimados cerca de 19 milhões de consumidores, segundo a Organização Mundial de Saúde, no ano de 2018. Esta substância psicoativa atua, a nível cerebral, no sistema límbico, o qual é responsável pela regulação das emoções e dos comportamentos sociais, o
APA, Harvard, Vancouver, ISO, and other styles
8

Fang, Yu-Hua, and 方佑華. "Non-invasive approaches for measuring the cerebral metabolic rate of glucose with FDG-PET images." Thesis, 2002. http://ndltd.ncl.edu.tw/handle/85811187639139275519.

Full text
Abstract:
碩士<br>國立陽明大學<br>醫學工程研究所<br>90<br>The quantitative analysis of [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) is able to provide an absolute value of the cerebral metabolic rate of glucose (CMRGlc) for the diagnosis of various brain functions; however, an input function from about 20 arterial blood samples is necessary for such a study. Due to the invasive nature of the blood sampling schedule, FDG-PET quantitative analysis is seldom performed in routine procedures. This study proposes two new techniques for estimating the input function without any blood samples. Method
APA, Harvard, Vancouver, ISO, and other styles
9

FREDDI, ILARIA. "Quantificazione del Rate Metabolico Cerebrale del Glucosio nella 18F-FDG-PET." Doctoral thesis, 2011. http://hdl.handle.net/2158/609080.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Cerebral FDG PET"

1

Heiss, W. D., G. Pawlik, K. Herholz, R. Wagner, and K. Wienhard. "Determination of Regional Glucose Metabolism in the Brain by FDG and PET." In Cerebral Blood Flow and Metabolism Measurement. Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-70054-5_59.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Biassoni, Lorenzo, Helen Nadel, and Zvi Bar-Sever. "Central Nervous System: The Brain and Cerebro-Spinal Fluid." In A Practical Guide for Pediatric Nuclear Medicine. Springer Berlin Heidelberg, 2023. http://dx.doi.org/10.1007/978-3-662-67631-8_2.

Full text
Abstract:
AbstractNuclear medicine studies of the central nervous system provide unique information on cerebral perfusion and metabolism and the physiology of cerebro-spinal fluid (CSF) fluid. Diagnosis of brain death is based on clinical findings indicating a complete lack of function of the entire brain. Mandatory additional studies supporting the clinical suspicion are required by most countries, such as electroencephalography (EEG), brainstem evoked response audiometry (BERA), transcranial Doppler, and brain scintigraphy. Brain scans following the administration of perfusion agents are considered to
APA, Harvard, Vancouver, ISO, and other styles
3

Boecker, H., T. Kuwert, K. J. Langen, et al. "Untersuchung des regionalen cerebralen Glukoseverbrauchs mit FDG-PET und des rCBF mit 99mTC-HMPAO-SPECT bei Patienten mit Morbus Huntington: ein Methodenvergleich." In Topographische Diagnostik des Gehirns. Springer Vienna, 1995. http://dx.doi.org/10.1007/978-3-7091-9415-7_107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Høilund-Carlsen, Poul F., Abass Alavi, and Jorge R. Barrio. "PET/CT/MRI in Clinical Trials of Alzheimer’s Disease." In Advances in Alzheimer’s Disease. IOS Press, 2024. https://doi.org/10.3233/aiad240044.

Full text
Abstract:
With the advent of PET imaging in 1976, 2-deoxy-2-[18F]fluoro-D-glucose (FDG)-PET became the preferred method for in vivo investigation of cerebral processes, including regional hypometabolism in Alzheimer’s disease. With the emergence of amyloid-PET tracers, [11C]Pittsburgh Compound-B in 2004 and later [18F]florbetapir, [18F]florbetaben, and [18F]flumetamol, amyloid-PET has replaced FDG-PET in Alzheimer’s disease anti-amyloid clinical trial treatments to ensure “amyloid positivity” as an entry criterion, and to measure treatment-related decline in cerebral amyloid deposits. MRI has been used
APA, Harvard, Vancouver, ISO, and other styles
5

Senda, Michio, Hinako Toyama, Yoko Ikoma, Yuichi Kimura, Koji Uemura, and Kenji Ishii. "Accuracy of FDG Images as a Measure of Cerebral Glucose Metabolic Rate." In Physiological Imaging of the Brain with PET. Elsevier, 2001. http://dx.doi.org/10.1016/b978-012285751-5/50019-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

van Veen R., Talavera Martinez L., Kogan R.V., et al. "Machine Learning Based Analysis of FDG-PET Image Data for the Diagnosis of Neurodegenerative Diseases." In Frontiers in Artificial Intelligence and Applications. IOS Press, 2018. https://doi.org/10.3233/978-1-61499-929-4-280.

Full text
Abstract:
Alzheimer's disease (AD) and Parkinson's disease (PD) are two common, progressive neurodegenerative brain disorders. Their diagnosis is very challenging at an early disease stage, if based on clinical symptoms only. Brain imaging techniques such as [18F]-fluoro-deoxyglucose positron emission tomography (FDG-PET) can provide important additional information with respect to changes in the cerebral glucose metabolism. In this study, we use machine learning techniques to perform an automated classification of FDG-PET data. The approach is based on the extraction of features by applying the scaled
APA, Harvard, Vancouver, ISO, and other styles
7

MURASE, K., H. KUWABARA, E. MEYER, A. C. EVANS, and A. GJEDDE. "Mapping of Change in Cerebral Glucose Utilization Using [18F]FDG Double Injection and New Graphical Analysis." In Quantification of Brain Function Using PET. Elsevier, 1996. http://dx.doi.org/10.1016/b978-012389760-2/50083-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Fernandes, Mariana, Agostino Chiaravalloti, Natalia Manfredi, et al. "Nocturnal Hypoxia and Sleep Fragmentation May Drive Neurodegenerative Processes: The Compared Effects of Obstructive Sleep Apnea Syndrome and Periodic Limb Movement Disorder on Alzheimer’s Disease Biomarkers." In Handbook of Prevention and Alzheimer’s Disease. IOS Press, 2024. http://dx.doi.org/10.3233/aiad230032.

Full text
Abstract:
Background: Sleep disorders may cause dysregulation in cerebral glucose metabolism and synaptic functions, as well as alterations in cerebrospinal fluid (CSF) biomarker levels. Objective: This study aimed at measuring sleep, CSF Alzheimer’s disease (AD) biomarkers, and cerebral glucose consumption in patients with obstructive sleep apnea syndrome (OSAS) and patients with periodic limb movement disorder (PLMD), compared to controls. Methods: OSAS and PLMD patients underwent 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET), polysomnographic monitoring, and lumbar puncture
APA, Harvard, Vancouver, ISO, and other styles
9

Tzimopoulou Sofia, Cunningham Vincent J., Nichols Thomas E., et al. "Validation and Pilot Application of [." In Advances in Alzheimer’s Disease. IOS Press, 2011. https://doi.org/10.3233/978-1-60750-793-2-627.

Full text
Abstract:
Here we describe methods for application of quantitative fluorodeoxyglucose positron emission tomography ([18F]FDG-PET) measures of brain glucose metabolism in multi-centre clinical trials for Alzheimer's disease. We validated methods and demonstrated their use in the context of a treatment trial with the PPAR&amp;gamma; agonist Rosiglitazone XR versus placebo in mild to moderate AD patients. Novel quantitative indices related to the combined forward rate constant for [18F]FDG uptake \(({K}_{i}^{index})\) and to the rate of cerebral glucose utilization \((CM{R}_{glu}^{index})\) were applied. A
APA, Harvard, Vancouver, ISO, and other styles
10

Triumbari, Elizabeth Katherine Anna, Agostino Chiaravalloti, Orazio Schillaci, Nicola Biagio Mercuri, and Claudio Liguori. "Positron Emission Tomography/Computed Tomography Imaging in Therapeutic Clinical Trials in Alzheimer’s Disease: An Overview of the Current State of the Art of Research." In Advances in Alzheimer’s Disease. IOS Press, 2024. https://doi.org/10.3233/aiad240045.

Full text
Abstract:
The integration of positron emission tomography/computed tomography (PET/CT) has revolutionized the landscape of Alzheimer’s disease (AD) research and therapeutic interventions. By combining structural and functional imaging, PET/CT provides a comprehensive understanding of disease pathology and response to treatment assessment. PET/CT, particularly with 2-deoxy-2-[fluorine-18]fluoro-D-glucose (18F-FDG), facilitates the visualization of glucose metabolism in the brain, enabling early diagnosis, staging, and monitoring of neurodegenerative disease progression. The advent of amyloid and tau PET
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cerebral FDG PET"

1

Blagosklonov, Oleg, Guennady I. Podoprigora, Sergey V. Pushkin, et al. "Correlation between direct microscopy and FDG-PET in the study of cerebral blood flow in rats." In European Conference on Biomedical Optics. OSA, 2007. http://dx.doi.org/10.1364/ecbo.2007.6626_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Blagosklonov, Oleg, Guennady I. Podoprigora, Sergey V. Pushkin, et al. "Correlation between direct microscopy and FDG-PET in the study of cerebral blood flow in rats." In European Conference on Biomedical Optics, edited by Kai Licha and Vasilis Ntziachristos. SPIE, 2007. http://dx.doi.org/10.1117/12.727945.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Machado, Luiza, Camila Santos, Bianca Leonardi, et al. "ACUTE PERIPHERAL INFLAMMATION IMPACT ON CEREBRAL GLUCOSE METABOLISM." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda072.

Full text
Abstract:
Background: Neuroinflammation is a phenomenon already described in Alzheimer’s disease (AD). However, the effect of peripheral inflammation in AD is less understood. We recently demonstrated that severe sepsis causes acute brain metabolic disturbances. Nevertheless, whether mild acute peripheral inflammation affects brain metabolism remains unclear. Objective: We aimed at investigating the impact of mild acute peritonitis on glucose brain metabolism. Methods: Adult male wistar rats (n=6, per group) received a single intraperitoneal injection of 500 ml of carrageenan (CG, 500 µg of carrageenan
APA, Harvard, Vancouver, ISO, and other styles
4

Beltrão, Thais Winkeler, Luiz Eduardo Duarte Borges Nunes, Simone Cristina Soares Brandão, and Breno José Alencar Pires Barbosa. "Phenotypic and neuroimage differences in Corticobasal syndrome from two clinical cases." In XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.470.

Full text
Abstract:
Corticobasal syndrome (CBS) is a neurodegenerative condition characterized by cognitive and motor symptoms and neurologic-functional progressive deterioration. The phenotypes can be associated with the underlying proteinopathies like Corticobasal Degeneration (CBD), Progressive Supranuclear Palsy or Alzheimer’s Disease (AD). This work aimed to study, in two cases, the correlations between clinical phenotypes, neuroimage markers and the underlying pathology. Clinical and neuroimage data of two patients was revised. The patient 1, 62-year-old, female, incomplete elementary school, presented prog
APA, Harvard, Vancouver, ISO, and other styles
5

Dai, Xiaoqian, Jie Tian, and Zhe Chen. "Improved estimation of parametric images of cerebral glucose metabolic rate from dynamic FDG-PET using volume-wise principle component analysis." In SPIE Medical Imaging, edited by Robert C. Molthen and John B. Weaver. SPIE, 2010. http://dx.doi.org/10.1117/12.843876.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Riehl, E., FA Verburg, M. Luster, and D. Librizzi. "Klinische Relevanz der cerebralen FDG-PET/CT-Bildgebung für das Therapiemanagement neurodegenerativer Erkrankungen." In NuklearMedizin 2019. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1683658.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Cerebral FDG PET' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography